RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA

Primary Sponsor

Trial Contact

qa@trog.com.au

Related Post

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team

17 September, 2026

TROG trial of new lung cancer radiation therapy approach opens

LATEST NEWS: 17 September 2026 The first Australian site